[{"NetIncomeLossConverted_1_Q2_USD":966429000.0,"NetIncomeLossConverted_2_Q2_USD":1652341000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":29652000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":29759000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":154930000.0,"EarningsPerShareDiluted_1_Q2_USD":32.15,"EarningsPerShareDiluted_2_Q2_USD":54.84,"StockholdersEquity_0_Q2_USD":7353402000.0,"RevenuesConverted_1_Q2_USD":536880000.0,"RevenuesConverted_2_Q2_USD":1108524000.0,"Assets_0_Q2_USD":10097307000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":30131000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":30058000.0,"EarningsPerShareBasic_1_Q2_USD":32.59,"EarningsPerShareBasic_2_Q2_USD":55.52,"Ticker":"BIO","CIK":"12208","name":"BIO-RAD LABORATORIES, INC.","OfficialName":"Bio-Rad Laboratories Inc. Class A Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"16656203893.0","Country":"United States","Sector":"Capital Goods","Industry":"Biotechnology: Laboratory Analytical Instruments","Market":"NYSE","SP500":"SP500","filed":"20200731"}]